Compare OGI & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGI | QTRX |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.0M | 160.0M |
| IPO Year | 2015 | 2017 |
| Metric | OGI | QTRX |
|---|---|---|
| Price | $1.02 | $4.28 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 554.6K | ★ 1.2M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $37,632,000.00 |
| Revenue This Year | $20.10 | $25.49 |
| Revenue Next Year | $13.92 | $10.04 |
| P/E Ratio | $13.91 | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $0.92 | $2.40 |
| 52 Week High | $2.24 | $8.77 |
| Indicator | OGI | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 66.20 |
| Support Level | $0.92 | $2.98 |
| Resistance Level | $1.21 | $6.27 |
| Average True Range (ATR) | 0.05 | 0.37 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 64.29 | 86.25 |
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.